KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Accounts Payables (2018 - 2025)

Historic Accounts Payables for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $467.4 million.

  • BioNTech SE's Accounts Payables fell 4419.26% to $467.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $467.4 million, marking a year-over-year decrease of 4419.26%. This contributed to the annual value of $456.0 million for FY2024, which is 1971.39% up from last year.
  • Latest data reveals that BioNTech SE reported Accounts Payables of $467.4 million as of Q3 2025, which was down 4419.26% from $570.7 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Accounts Payables ranged from a high of $949.3 million in Q2 2024 and a low of $32.1 million during Q1 2023
  • In the last 5 years, BioNTech SE's Accounts Payables had a median value of $310.6 million in 2022 and averaged $367.3 million.
  • Per our database at Business Quant, BioNTech SE's Accounts Payables tumbled by 7688.38% in 2023 and then skyrocketed by 91145.34% in 2024.
  • Quarter analysis of 5 years shows BioNTech SE's Accounts Payables stood at $183.0 million in 2021, then grew by 13.77% to $208.2 million in 2022, then skyrocketed by 82.91% to $380.9 million in 2023, then increased by 19.71% to $456.0 million in 2024, then rose by 2.5% to $467.4 million in 2025.
  • Its Accounts Payables stands at $467.4 million for Q3 2025, versus $570.7 million for Q2 2025 and $466.8 million for Q1 2025.